Ivosidenib can reduce the production of the oncogenic metabolite 2-HG by selectively targeting and inhibiting the activity of the mutant IDH1 enzyme.
Authentic
Guarantee
Fast Delivery
Privacy Ivosidenib Indications1. LeukemiaIvosidenib, used in combination with azacitidine or as monotherapy, is indicated for newly diagnosed acute myeloid le···【Read More】
Update: 09 Mar,2026Source: Haiou HealthViews: 71
In addition to its expected therapeutic effects, some adverse side effects may occur during treatment with ivosidenib. While not all side effects will···【Read More】
Update: 09 Mar,2026Source: Haiou HealthViews: 71
Copyright2024@ BIGBEAR All right reserved BIGBEAR



